Ad is loading...
GABIX
Price
$53.60
Change
-$0.28 (-0.52%)
Updated
Nov 15 closing price
VSTSX
Price
$278.21
Change
-$3.68 (-1.31%)
Updated
Nov 15 closing price
Ad is loading...

GABIX vs VSTSX

Header iconGABIX vs VSTSX Comparison
Open Charts GABIX vs VSTSXBanner chart's image
Gabelli Asset I
Price$53.60
Change-$0.28 (-0.52%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$278.21
Change-$3.68 (-1.31%)
VolumeN/A
CapitalizationN/A
GABIX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GABIX vs. VSTSX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABIX is a StrongBuy and VSTSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.73T vs. GABIX (1.66B). VSTSX pays higher dividends than GABIX: VSTSX (1.36) vs GABIX (0.52). GABIX was incepted earlier than VSTSX: GABIX (17 years) vs VSTSX (8 years). GABIX is a more actively managed with annual turnover of: 4.00 vs. VSTSX (2.00). GABIX has a lower initial minimum investment than VSTSX: GABIX (500000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 30.56 vs. GABIX (10.93). VSTSX return over 5 years is better than : 83.83 vs. GABIX (-6.05).
GABIXVSTSXGABIX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years8 years-
Gain YTD10.97322.44349%
Front LoadN/AN/A-
Min. Initial Investment50000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B1.73T0%
Annual Yield % from dividends0.521.3639%
Returns for 1 year10.9330.5636%
Returns for 3 years-15.7419.98-79%
Returns for 5 years-6.0583.83-7%
Returns for 10 years-17.71N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MS134.061.63
+1.23%
Morgan Stanley
OLN41.39-0.43
-1.03%
Olin Corp
SPNS28.00-0.56
-1.96%
Sapiens International Corp
RVNC4.17-0.14
-3.25%
Revance Therapeutics
VTGN2.63-0.10
-3.66%
VistaGen Therapeutics